AAAAAA

   
Results: 1-10 |
Results: 10
Enzyme replacement therapy in Fabry disease - A randomized controlled trial
Authors: Schiffmann, R Kopp, JB Austin, HA Sabnis, S Moore, DF Weibel, T Balow, JE Brady, RO
Citation: R. Schiffmann et al., Enzyme replacement therapy in Fabry disease - A randomized controlled trial, J AM MED A, 285(21), 2001, pp. 2743-2749
Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis
Authors: Illei, GG Austin, HA Crane, M Collins, L Gourley, MF Yarboro, CH Vaughan, EM Kuroiwa, T Danning, CL Steinberg, AD Klippel, JH Balow, JE Boumpas, DT
Citation: Gg. Illei et al., Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis, ANN INT MED, 135(4), 2001, pp. 248-257
Progress in the treatment of proliferative lupus nephritis
Authors: Balow, JE Austin, HA
Citation: Je. Balow et Ha. Austin, Progress in the treatment of proliferative lupus nephritis, CURR OP NEP, 9(2), 2000, pp. 107-115
Increased levothyroxine requirements presenting as "inappropriate" TSH secretion syndrome in a patient with nephrotic syndrome
Authors: Collins, MT Remaley, AT Csako, G Pucino, F Skarulis, MC Balow, JE Sarlis, NJ
Citation: Mt. Collins et al., Increased levothyroxine requirements presenting as "inappropriate" TSH secretion syndrome in a patient with nephrotic syndrome, J ENDOC INV, 23(6), 2000, pp. 383-392
Treatment of lupus nephritis
Authors: Austin, HA Balow, JE
Citation: Ha. Austin et Je. Balow, Treatment of lupus nephritis, SEM NEPHROL, 20(3), 2000, pp. 265-276
New prospects for treatment of lupus nephritis
Authors: Balow, JE Boumpas, DT Austin, HA
Citation: Je. Balow et al., New prospects for treatment of lupus nephritis, SEM NEPHROL, 20(1), 2000, pp. 32-39
A pilot study of low-dose fludarabine in membranous nephropathy refractoryto therapy
Authors: Boumpas, DT Tassiulas, IO Fleisher, TA Vaughan, E Piscitelli, S Kim, Y Pucino, F Balow, JE Austin, HA
Citation: Dt. Boumpas et al., A pilot study of low-dose fludarabine in membranous nephropathy refractoryto therapy, CLIN NEPHR, 52(2), 1999, pp. 67-75
Natural history and treatment of lupus nephritis
Authors: Austin, HA Balow, JE
Citation: Ha. Austin et Je. Balow, Natural history and treatment of lupus nephritis, SEM NEPHROL, 19(1), 1999, pp. 2-11
Renal biopsy in lupus nephritis
Authors: Grande, JP Balow, JE
Citation: Jp. Grande et Je. Balow, Renal biopsy in lupus nephritis, LUPUS, 7(9), 1998, pp. 611-617
Outcome criteria for lupus nephritis trials: A critical overview
Authors: Boumpas, DT Balow, JE
Citation: Dt. Boumpas et Je. Balow, Outcome criteria for lupus nephritis trials: A critical overview, LUPUS, 7(9), 1998, pp. 622-629
Risultati: 1-10 |